Cognitive Disorders

From the relationship between glucose fluctuations and cognition in patients with type 1 diabetes to augmentation strategies for treatment-resistant depression, here are highlights from the week in Psychiatric Times.

A new study found that when glucose is either very high or low in patients with type 1 diabetes, cognition is slower; however, slightly above average glucose led to peak cognitive performance.

From mild cognitive impairment and serotonin system degeneration to an update on pimavanserin for negative symptoms of schizophrenia, here are highlights from the week in Psychiatric Times.

“If we can show that serotonin loss over time is directly involved in the transition from mild cognitive impairment to Alzheimer disease, recently developed antidepressant medications may be an effective way to improve memory deficits and depressive symptoms and, thus, may be a powerful way forward to slow disease progression.”

The screening tool includes multiple tests that assess memory, attention, executive function, reaction times, and motor function.

A new study correlates reduced serotonin transporter and increased amyloid-ß deposition with cognitive deficits in mild cognitive impairment, suggesting a role for serotonergics in early Alzheimer disease.

What is new in research on sleep?

Check out these brief summaries on cognitive impairment in schizophrenia from an excellent session at the ACNP 2023 Annual Meeting!

A new cognitive biotype for depression may impact symptoms and treatment outcomes.

A look at one of the most informative yet easy-to-administer tests for assessing brain dysfunction.

What are the available and upcoming AD treatments and how can you utilize them to best serve your patients?

Are you ready to understand how recovery-oriented cognitive therapy (CT-R) promotes wellness and empowerment for individuals experiencing serious mental health challenges? Check out this CME article.

VR-based training may help improve social cognition and functioning in patients with schizophrenia.

What's the latest in dementia?

Cognitive and psychiatric symptoms at 3 months post-stroke might predict daytime sleepiness and fatigue at 12 months.

From evidence-based novel therapies for bipolar depression to potential indicators of early-stage Alzheimer disease, here are highlights from the week in Psychiatric Times.

Results show comparisons between intranasal and intracerebroventricular distribution of an oxytocin derivative.

Can Alzheimer disease research offer the key to effective treatment?

A reminder to cherish your parents and the older adults in your life.

How does COVID-19 contribute to cognitive impairment in older adults and future cases of dementia?

With the growing elderly population and the prevalence of cognitive impairment, how can we protect older adults from financial scams?

A study compared matcha, a highly caffeinated green tea, to other sources of caffeine. Which had the greatest cognitive benefits?

Statistical findings from longitudinal studies of mental health among 9/11 witnesses and first responders.

A growing body of scientific literature makes the case.

The world is facing a cognition crisis. Here’s how to face it with measurement-based cognitive care.

Sleep problems are understudied, underdiagnosed, and undertreated.

When do cognitive impairments emerge in patients with schizophrenia?

Aerobic exercise has been found to exert a positive effect on global cognition and some, but not all, cognitive domains in patients with schizophrenia.

Neuropsychiatric manifestations of Huntington disease can present decades before the motor symptoms become apparent, making the role of the psychiatrist all the more important.

Brain health disorders cost the global economy more than $3 trillion per year in lost productivity. What can we do about it?